Pharmacoepidemiological studies based on the cohort design are simpler to analyse and their results easier to interpret. However, these may not reflect real-life drug use which is a major strength of such studies. The nested case-control design is often used instead to avoid the computational burden associated with time-dependent explanatory variables. Unlike the classical case-control design which is generally easy to programme, that of the nested case-control can pose a number of challenges. Subjects can be chosen as controls more than once and a subject who is chosen as a control can later become a case. Indeed controls are chosen from among those in the cohort who are at risk of the event at that time (i.e. we sample from the risk set defined by the case). We highlight the main programming challenges of the design as well as describe and demonstrate approaches for resolution and appropriate implementation.
INTRODUCTION
The randomized controlled trial (RCT) is universally considered as gold standard in drug research primarily because it is capable of providing the most compelling evidence on the efficacy of a healthcare intervention 1 . In a clinical trial, we conceal treatment allocation by a randomization process that we maintain through blinding to study participants. However, due to cost implications and other logistical considerations, features such as small sample size, short study duration and restricted populations often make trials inadequate for determining rates of adverse effects because of low frequencies. Today, many consider the post-marketing phase as the richest source of safety data and clinical trials constitute only a part of drug safety research. Pharmacoepidemiological studies on drug safety are becoming increasingly popular mainly because they reflect real-life utility of drugs, although evidence from these studies is often dismissed because of the absence of randomization and the likely consequences of selection bias due to confounding. Confounding is the problem that arises when the effect of a factor that is associated with both the outcome of interest and exposure is mixed up with the actual exposure effect.
Part of the reason for the increasing growth in these studies is because in some situations, a trial may be either inappropriate or inadequate or even impossible to conduct-making pharmacoepidemiological study the only alternative to doing nothing. The other is perhaps, because when properly conducted, these studies are capable of providing compelling information about the safety of drugs in certain populations and settings.
Cohort studies are by far the most common in epidemiological research. Although cohort studies which are based on intention-to-treat approach offer a simple design with data which are simpler to analyze and results easier to interpret, such studies also intrinsically assume that any time-varying treatment effect that exits can be adequately estimated by a fixed-effect component. However, such an assumption may not reflect real-life drug use. Indeed, where sophisticated models such as those involving time-varying components are used, these are usually based on assumptions which may be difficult to satisfy and their results similarly difficult to interpret. Another drawback of the cohort design for investigating the causes of disease with low incidence is that large and lengthy studies may be required to command adequate statistical power.
The case-control design is an alternative which avoids this difficulty. In the cohort design, we follow the entire cohort and measure the rate of occurrence of new cases in the different exposure groups to investigate possible relationship between exposure and disease incidence. The follow up allows us to identify those subjects who develop the disease during the study period as well as those who remain free of the disease. By contrast, in a classical case-control design, we identify the subjects who develop the disease (the cases) by some mechanism other than that of follow-up and a group of healthy subjects (the controls) is used to represent the subjects who do not develop the disease. Here, we try to control for the potential effects of confounding factors by matching on such covariates in preference over modeling the covariate effects. From programming perspective, the main challenge effectively depends on the size of the control population as well as the sampling procedure used to obtain the controls matched to the cases.
Studies based on the case-control design can be conducted and completed in a shorter time. Such studies generally require smaller sample sizes and hence are usually less expensive. In general, it is the only practical approach for identifying risk factors for rare diseases, especially where follow-up of a large sample for occurrence of the condition might be impractical. The design is particularly useful for reducing the labour and cost of data collection, assessing an exposure not measured in the original cohort and for avoiding the computational burden associated with multiple time-dependent explanatory variables.
In the case-control design, the period over which failures are registered as cases is called the study period and it is theoretically possible to choose controls to represent the entire source population at the start of the study period, including those who go on to become cases. However, this is rarely achievable by the classical approach, because the source population is often ill-defined especially in routinely collected databases such as those based on healthcare claims. The nested case-control version is used to overcome this problem as the controls that are matched to each case are obtained by sampling from the very cohort that gave rise to the cases. In other words, the controls for each case are chosen from among those in the cohort who are at risk of the event at that time (i.e. we sample from the risk set defined by the case). Intuitively, comparison of exposure between the case and controls in the risk sets does not require all the controls; a representative sample of the controls should be sufficient. Subjects can be chosen as controls more than once, and a subject who is chosen as a control can later become a case. Indeed, most safety-focused studies are based on this design so as to avoid the computational burden associated with time-dependent explanatory variables. The Cox regression is used to estimate the relative change in event rates per unit of increase in exposure, in which the case-control comparison from each risk set is quantified in a conditional logistic partial likelihood contribution.
The strength of the nested case-control design rests largely on the appropriateness of the controls matched to the cases-which can be quite daunting from programming perspective role is arguably the most vital in such a study. We need to sample the controls from the dynamic risk sets whilst ensuring the desired representative quality. We will highlight the main programming challenges of the design as well as describe and demonstrate approaches for resolution and appropriate implementation.
METHOD
There are various methods for sampling controls in nested case-control analyses but the method of incidence density sampling has been identified as the method of choice for obtaining unbiased results .2 An efficient incidence density sampling scheme is one in which controls are selected without replacement from all persons at risk at the time of case occurrence, excluding the index case itself. To use incidence density sampling to match controls to cases, the programmer must provide a data set (i.e. the that describes the study cohort and includes the relevant variables such as those that define the case and treatment exposure statuses of patients as well as those for matching. 4 Although some programs for incidence density sampling have been previously described elsewhere [5] [6] [7] , none of them is based on the SAS PROC SQL which offers a robust but simple approach to matching of patients on pre-defined variables.
As in the classical case-control study setting, data from a nested case-control study involve series of standard 2x2 contingency tables-each table being identified in SAS as a stratum, composing of four cells that represent the frequencies of cases and controls classified by exposure status in terms of whether each patient in the stratum is exposed or unexposed as shown in Table 1 . 
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In a typical nested case-control study involving incidence density sampling, each case will be matched to n controls (n>=1). Thus in the matched dataset, if a=1 (i.e. the case is exposed) then b=0 and vice versa for each stratum. Matching is usually on categorical variables such as age, gender, etc. and in general, the more variables that are involved in the matching of cases to controls, the smaller the matched study sample size. The macro %Macro is used to ensure no more than n controls are matched to each case. Lastly, the variable casecon defines the case status of patients in the matched dataset with casecon=1 for a case.
The %Macro is followed by six datasteps-primarily to construct the individual 2x2 matrices (i.e. Table 1) which will involve separating the matched cases from their matched controls; assigning censoring status flag casecon r a case and 0 for a control) and also obtaining relevant covariates in the full cohort on each case and control for analysis of the resulting data by conditional logistic regression. create  table  join1 as select distinct a.pateid_case, a.tcens, a.ageindex, a.gender, b.pateid, ranuni(12345) as rand_num from cases a inner join fullset b on (a.tcens) <=b.tcens /* control is in risk set at a.tcens */ and a.pateid_case ne b.pateid /* control is not the case */ and a.ageindex-1 <= b.ageindex <= a.ageindex+1 /* similar age +-1 */ and a.gender = b.gender /* control is same gender as case */ order by pateid_case, rand_num;; quit;; * Macro that selects n matched controls for each case *;; %Macro match(controlsnum);; data match(keep=pateid_case pateid);; set join1;; by pateid_case rand_num;; retain mcount;; mcount+1;; if first.pateid_case then mcount=1;; if mcount le &controlsnum;; run;; %mend match;; quit;; * Input the number of controls (n) to match to each case *;; %match(n);; * Output full dataset of matched cases and controls *;; data matched_cases_controls_all;; set match;; run;; proc printto;; run;; *To separate the matched cases from their matched controls for purpose of assigning event flag and also for obtaining the covariates in the database *;; data matched_cases_controls;; merge matched_cases_controls_all(in=a) pnsurv.study_all(in=b keep=pateid tcens rename=(pateid=pateid_case));; by pateid_case;; if a=1 and b=1;; run;; proc sort data=matched_cases_controls;; by pateid_case;; run;; * To retain the matching identifier (i.e. assign case identifier to its matched controls) for accurate update of the covariates at corresponding event time and assignment of censoring status *;; data case_id (keep=pateid pateid_case tcens);; set matched_cases_controls;; by pateid_case;; if first.pateid_case;; /* only the first observation to identify a case */ pateid=pateid_case;; /* make the case_id as the identifier */ run;; data id (keep= pateid pateid_case matchset tcens);; /*generate id to link cases with their matched sets */ set case_id;; by pateid_case;; matchset=_N_;; run;; proc sort data=matched_cases_controls;; by pateid;; run;; proc sort data=case_id;; by pateid;; run;; * To obtain follow-up time and if needed, generate updates of covariates for each matched control *;; data matched_cases_controls1;; merge matched_cases_controls case_id(keep= pateid pateid_case tcens);; by pateid pateid_case;; run;; proc sort data=matched_cases_controls1;; by pateid_case;; run;; data final_matched_temp;; /* Assign the matchset identifier to all records */ merge matched_cases_controls1 id(keep=pateid_case tcens matchset rename=(matchset=statu));; by pateid_case;; run;; proc sort data= final_matched_temp;; /* reordered by original identifier */ by pateid;; run;; data pnsurv.final_matched_all(drop=pateid_case);; /* ready for analysis */ set final_matched_temp;; if pateid=pateid_case then casecon=1;; else casecon=0;; run;;
CONCLUSION
Observational studies involving the nested case-control design are now commonplace and the trend of increased usage of the design in preference over the much simpler cohort design is likely to accelerate over time for a number of reasons, already described in epidemiological literature. [8] [9] [10] [11] The problem of time-varying treatment arguably provides the main rationale for the popularity of the nested case-control design in safety studies and today, most published pharmacoepidemiological safety studies are based on the design despite the known problems of bias associated with the design. [11] [12] To minimize the potential effects of confounding factors-the main source of bias-we match cases to controls on at least, the most important confounding covariates in preference over modeling their effects. This is a process that involves sampling of potential controls and although there are many sampling approaches, that of incidence density sampling is widely recognized as the best. From programming perspective, the main challenges depend on the size of the control population and appropriate implementation of the recommended sampling approach.
In this paper, we have described a simple approach for an accurate implementation of the nested casecontrol design based on a SAS program, generic enough for easy adaption to any given study involving the design. Our approach may be first to utilize the matching provision offered by SAS PROC SQL to achieve exact incidence density sampling from the dynamic risk sets of the nested case-control design, whilst also ensuring appropriate implementation of all the vital conditions of the design.
